Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07232017 · ClinicalTrials.gov registry record
Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic
A clinical trial of Hypertension (HTN), sponsored by Anita Misra-Hebert.
- Recruiting
- Registry status
- 1,520
- Enrollment target
- 1
- Study location
NCT07232017 is a study of Hypertension (HTN) that is actively recruiting participants, run by Anita Misra-Hebert. The registered enrollment target is 1,520 participants, below the 1,680-participant average among 3 other Hypertension (HTN) trials with a reported enrollment target (10% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07232017, a study of Hypertension (HTN), is actively recruiting participants, sponsored by Anita Misra-Hebert.
- RECRUITING
- Registry status
- 1,520 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of the Implementation of Effective Hypertension Management Approaches: Cleveland Clinic program is to improve blood pressure control for patients diagnosed with hypertension (HTN) and uncontrolled blood pressure, specifically defined as a blood pressure greater than 150/95, across all Cleveland Clinic Northeast Ohio primary care practices. The project will scale up the availability of resources for treating hypertension in 56 primary care practices within the Cleveland Clinic Health System in Northern Ohio, reaching up to approximately 3800 patients. This project will utilize evidence from a randomized controlled trial by Margolis et al.(1) to build upon Cleveland Clinic's existing team-based primary care provider (PCP) collaboration with pharmacists and advanced practice providers (APP) and will use a mechanism that allows titrating blood pressure medications based on patient-recorded home blood pressure readings.
Conditions Studied
Interventions
- OTHER IN-HOME BP
Study Locations (1)
Ohio
- Cleveland Clinic - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,520 participants |
| Start Date | 2026-01-06 |
| Est. Completion | 2029-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07232017
The ClinicalTrials.gov registry entry for NCT07232017 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,520 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,680-participant average among 3 other Hypertension (HTN) trials with a reported enrollment target (10% lower). The listed sponsor is Anita Misra-Hebert, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertension (HTN) appearing as the primary indexed condition, and to 1 intervention - of which IN-HOME BP is the first listed.
NCT07232017 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07232017 about?
NCT07232017 is a clinical study titled "Implementation of Intensive Hypertension Management Approaches: Cleveland Clinic". The primary objective of the Implementation of Effective Hypertension Management Approaches: Cleveland Clinic program is to improve blood pressure control for patients diagnosed with hypertension (HTN) and uncontrolled blood pressure, specifically defined as a blood pressure greater than 150/95, acr...
What is the current status of trial NCT07232017?
This trial is currently recruiting. The enrollment target is 1,520 participants. The study started on 2026-01-06. Estimated completion is 2029-07.
What conditions does trial NCT07232017 study?
This clinical trial studies the following conditions: Hypertension (HTN).
What interventions are being tested in trial NCT07232017?
The interventions under investigation include: IN-HOME BP (OTHER).
Who is sponsoring clinical trial NCT07232017?
This trial is sponsored by Anita Misra-Hebert, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07232017 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension (HTN)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study Comparing the Clinical Benefit of Finerenone Versus a Fixed Dose Combination (FDC) of Extended-Release Torsemide and Spironolactone in Patients With Hypertension and Chronic Kidney Disease
RECRUITING · Phase 3
-
Study of the Progression of Chronic Cardiovascular Conditions
RECRUITING
-
Mediterranean-DASH Intervention for Neurodegenerative Delay and High-Intensity Interval Training in Adults With Hypertension
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.